Yuk Ting Ma Selected Research

Yuk Ting Ma Research Topics

9	Neoplasms (Cancer) 11/2023 - 05/2008
8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2016
5	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2023 - 01/2019
4	Adenocarcinoma 01/2023 - 11/2017
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 09/2017
3	Cholangiocarcinoma 01/2022 - 01/2019
2	Infections 01/2023 - 01/2021
2	Gallbladder Neoplasms (Gallbladder Cancer) 01/2022 - 01/2019
2	Fatigue 01/2019 - 01/2017
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 10/2008 - 05/2008
1	Melanoma (Melanoma, Malignant) 11/2023
1	Neutropenia 01/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Disease Progression 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Febrile Neutropenia 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Hand-Foot Syndrome 01/2019
1	Heart Failure 01/2018
1	Ischemia 01/2018
1	Necrosis 01/2018
1	Cardiotoxicity 01/2018
1	Cholecystitis 01/2018
1	Virus Diseases (Viral Diseases) 02/2017
1	Chronic Hepatitis C 02/2017
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2017
1	Abdominal Pain (Pain, Abdominal) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 08/2011

7	Gemcitabine FDA Link 01/2023 - 09/2017
6	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 12/2016
4	Capecitabine (Xeloda)FDA Link 01/2023 - 11/2017
2	bexmarilimabIBA 11/2023 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 05/2008
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 11/2017
2	Leucovorin (Folinic Acid)FDA Link 01/2021 - 11/2017
1	Estrogen ReceptorsIBA 11/2023
1	folfirinoxIBA 01/2023
1	Cancer VaccinesIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Vitamin K FDA Link 11/2021
1	acarboxyprothrombin (PIVKA)IBA 11/2021
1	Prothrombin (Factor II)IBA 11/2021
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2021
1	LipidsIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Sunitinib (Sutent)FDA Link 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	CytokinesIBA 01/2021
1	N 30IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	AntibodiesIBA 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	AntigensIBA 01/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	N- (3,4- difluoro- 2- (2- fluoro- 4- iodophenylamino)- 6- methoxyphenyl)- 1- (2,3- dihydroxypropyl)cyclopropane- 1- sulfonamideIBA 10/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2018
1	Histone Deacetylase InhibitorsIBA 09/2017
1	entinostat (MS 275)IBA 09/2017
1	BilirubinIBA 12/2016
1	AlbuminsIBA 12/2016

8	Drug Therapy (Chemotherapy) 01/2021 - 05/2008
7	Therapeutics 11/2023 - 10/2008
3	Adjuvant Chemotherapy 01/2023 - 01/2018
3	Immunotherapy 01/2022 - 01/2020
1	Neoadjuvant Therapy 01/2023
1	Chemoradiotherapy 01/2023
1	Radiotherapy 01/2019
1	Hepatectomy 01/2018
1	Conservative Treatment 01/2018
1	Combination Drug Therapy (Combination Chemotherapy) 05/2008